Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications.

Current topics in medicinal chemistry

Volumn 2, Issue 9, 2002, Pages 915-938

  Bullock, William H ^a   Magnuson, Steven R ^a   Choi, Soongyu ^a   Gunn, David E ^a   Rudolph, Joachim ^a  

^a BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ENZYME INHIBITOR; GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DIABETES MELLITUS; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOGEN SYNTHASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0036716566     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026023393255     Document Type: Review

References (251)